Synthesis method of drug Tafamidis

A synthesis method and drug technology, applied in the field of synthesis of the drug Tafamidis, can solve the problems of only 43%, potential safety hazards, and high price of diaryliodonium compounds

Pending Publication Date: 2021-09-10
ZUNYI MEDICAL UNIVERSITY
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The currently reported methods for synthesizing the drug Tafamidis mainly include (1) the original research route of the drug (KellyJ.W.; et alAngew. Chem. Int. Edit. 2003, 42 , 2758; Kelly J.W.; et al WO2004056315, etc.) as shown in the figure below, but this method has the following disadvantages: ① Trimethylsilyldiazomethane (TMSCHN 2 ), the reagent is relatively expensive and has potential safety hazards; ② the total yield of the reaction is only 10%, and the yield is low; ③ when preparing intermediate 5, the product needs to be purified by column chromatography, which limits its industrial application application
[0006] (2) Itami et al reported the use of nickel-catalyzed aryl coupling reaction as a key step to synthesize the drug Tafamidis (Itami, K.; et alChem. Eur. J. 2011, 17 , 10113) as shown in the figure below, but this method has the following disadvantages: ① need to use potentially dangerous hydrogen fluoride pyridine solution; ② use metallic nickel as a catalyst, which may cause heavy metal residues; ③ multi-step reactions in this route need to pass through the column layer Analysis and purification of the product limit its industrial application
[0008] (3) Su et al reported the use of palladium-catalyzed C-C coupling reaction as a key step to prepare the precursor of the drug Tafamidis (Su, W.; et al Chem. Commun. 2012, 48 , 8964) as shown in the figure below, but this method has the following disadvantages: ① need to use precious metal palladium; ② use metal palladium and copper as catalysts, which may cause metal residues and the yield is only 43%; ③ there is a problem of regioselectivity, And the by-product 12 is difficult to separate from the Tafamidis precursor 5; ④ The reaction needs to be separated and purified by column chromatography, which limits its industrial application
[0010] (4) Kumar et al reported the use of copper-catalyzed direct C-H bond arylation reaction as a key step to synthesize the precursor of Tafamidis (Kumar, D.; et al Org Biomol Chem. 2014, 12 , 6340) as shown in the figure below, but this method has the following disadvantages: ① the price of diaryliodonium compounds is expensive; ② using copper as a catalyst may lead to metal residues; ③ the reaction needs to be separated and purified by column chromatography, which limits its Application in industrialization
[0012] (5) The synthesis of benzoxazole ring from amidoxime under the promotion of iodine as a key step to synthesize the precursor of Tafamidis reported by Ji et al. (Ji, M.; et al Eur. J. Org. Chem. 2019, 7506.) as shown in the figure below, but this method has the following disadvantages: ① The synthesis yield of amidoxime 16 and the synthesis yield of Tafamidis precursor 17 are only 51% and 46%, respectively, and the yield is low; ② The reaction requires Separation and purification by column chromatography limits its industrial application
[0014] (5) Karumanchi et al reported the synthesis of Tafamidis from 3-hydroxy-4-nitrobenzoic acid through esterification, reduction and ring closure reactions (Karumanchi, K.; et al J. Chem. Sci. 2021, 133 , 48) as shown in the figure below, but this method has the following disadvantages: ① Using metal zinc as a reducing agent may lead to metal residues; ② The total yield of the reaction is 44%, and the yield is low; ③ It requires 7 times the equivalent of metal Zinc as a reducing agent is less economical; ④ Metal zinc and methanesulfonic acid are used as a reducing agent, and a large amount of muddy zinc salt will be generated after the reaction, which will cause serious environmental pollution, and at the same time bring difficulties and restrictions to the cleaning of instruments and pipelines. Its application in industrialization
[0016] (6) A method for synthesizing benzoxazole compounds disclosed by Tan Meimei et al. to synthesize Tafamidis (Tan Meimei et al., 2018, CN: 108484517) is shown in the figure below, but this method has the following deficiencies: ① Raw materials Compound 20 is more expensive; ② Although this patent does not disclose the yield of synthesizing Tafamidis by using this method, the yield of other analogues disclosed by it is 48%-52%. It can be inferred that the yield of synthesizing Tafamidis by this method is relatively Low; ③ It can be known from other analogue examples disclosed that this method needs to separate and purify the product by column chromatography, thus limiting its industrial application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of drug Tafamidis
  • Synthesis method of drug Tafamidis
  • Synthesis method of drug Tafamidis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1, the compound shown in preparation formula Ia structure

[0048] The reaction formula is as follows:

[0049]

[0050] Add magneton, compound 1 (1.531 g, 10 mmol) and methanol (31 mL) into a clean reaction flask in sequence, then slowly add concentrated sulfuric acid (3.1 mL) dropwise under stirring at room temperature, and then heat up to reflux for reaction . TLC shows that after the reaction of raw materials is completed (about 4 hours), let it cool down to room temperature, add saturated sodium bicarbonate solution to it until the pH reaches alkaline, filter with diatomaceous earth, concentrate the filtrate and transfer it to a separatory funnel with ethyl acetate , washed with water and saturated sodium chloride solution respectively, the organic phase was dried over anhydrous sodium sulfate and filtered, and the filtrate was concentrated and vacuum-dried to obtain 1.572 g of a brown solid, with a yield of 94%. 1 H NMR (400 MHz, DMSO-d6) δ 9.44 (s...

Embodiment 2

[0051] Embodiment 2, the compound shown in preparation formula IIIa structure

[0052] The reaction formula is as follows:

[0053]

[0054] Into a clean reaction flask, add magnetons, compound of formula Ia (0.836 g, 5 mmol), pyridine (1.187 g, 15 mmol) and tetrahydrofuran (74 mL), and then add compound of formula IIa (1.047 g, 5 mmol), let it react at room temperature after the addition. TLC showed that after the completion of the reaction of the raw materials (about 6 hours), the reaction solution was directly concentrated and dissolved in ethyl acetate, then transferred to a separatory funnel, washed with saturated sodium bicarbonate, 10% hydrochloric acid and saturated sodium chloride, and the organic phase Anhydrous sodium sulfate was dried and filtered, and the filtrate was concentrated and vacuum-dried to obtain 1.680 g of a brown solid with a yield of 99%. 1 H NMR (400 MHz, DMSO-d6) δ 10.33 (brs, 1H), 9.88 (brs, 1H), 7.97 (d, J = 1.8Hz, 2H), 7.89 – 7.83 (m, 2H), ...

Embodiment 3

[0055] Embodiment 3, the compound shown in preparation formula IVa structure

[0056] The reaction formula is as follows:

[0057]

[0058] Into a clean reaction bottle, add magneton, compound of formula IIIa (0.340 g, 1 mmol), p-toluenesulfonic acid monohydrate (0.038 g, 0.2 mmol) and toluene (8 mL), after the addition, heat up to reflux reaction. TLC shows that after the raw material has reacted (about 12 hours), let it cool to room temperature and add 1 mol / L sodium hydroxide solution thereinto until the pH reaches alkalinity, then add an appropriate amount of water and ethyl acetate to the above solution, Then it was transferred to a separatory funnel, the organic phase was separated and then washed with saturated sodium chloride, the organic phase was dried over anhydrous sodium sulfate and filtered, the filtrate was concentrated and vacuum-dried to obtain 0.320 g of light pink solid, collected 99% rate, 1 H NMR (400 MHz, CDCl 3 ) δ 8.27 (s, 1H), 8.14 (s,2H), 8.11 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthesis method of a drug Tafamidis. According to the synthesis method, 3-hydroxy-4-amidobenzoic acid is used as a raw material, and the drug Tafamidis is prepared through esterification, amidation, cyclization and hydrolysis reaction. According to the method, concentrated sulfuric acid and methanol are used for replacing expensive and dangerous trimethylsilyl diazomethane to carry out methylation reaction of carboxyl; in the cyclization reaction, the dosage of p-toluenesulfonic acid is obviously reduced; reaction post-treatment is simplified, column chromatography for product purification is not needed in each step of reaction, the total yield of the reaction is remarkably increased, and the method is more suitable for industrial production.

Description

technical field [0001] The invention belongs to the field of organic synthesis and pharmacy, in particular to a method for synthesizing the drug Tafamidis. Background technique [0002] Rare diseases, also known as "orphan diseases", refer to diseases with extremely low incidence. There are certain differences in the identification standards of rare diseases in different countries in the world according to their specific conditions. There is no official standard for rare diseases in China. One in 500,000 (0.002‰) diseases are identified as rare diseases, and they are divided into four categories and 43 types, with an estimated 10-20 million cases. Transthyretin-related familial amyloidosis polyneuropathy (TTR-FAP) is a lethal chromosomal dominant genetic rare disease with malignant progression, which was first discovered in 1952 by Portuguese physician Andrade. The pathogenesis of the disease is the abnormal deposition of transthyretin-type amyloid in tissues due to TTR ge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D263/57
CPCC07D263/57
Inventor 张韵陈晓婷陈永正牟学清张磊周晓建
Owner ZUNYI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products